New immune system enhancer extends COVID-19 vaccine protection reducing need for repeated boosters
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Oct-2026 13:16 ET (21-Oct-2026 17:16 GMT/UTC)
In a new study published in Nature Immunology, researchers at Boston Children’s Hospital demonstrated that pairing the original COVID-19 mRNA vaccine with an immune system enhancer, known as an adjuvant, improved the duration of the vaccine’s protection in mice. The combo also showed a more pronounced response against omicron viral components than the vaccine alone. The researchers say that introducing adjuvants like this one to mRNA vaccines may alleviate the need for frequent boosters due to waning antibodies or new viral variants.
A large-scale study of human mobility and wildlife movement across the United States suggests that the day-to-day presence of humans – not just how they alter the landscape – is a major ecological force that shapes how animals move through and use their environments, researchers report. Human activity is accelerating global biodiversity loss by transforming climates and rapidly reshaping natural landscapes. Yet beyond these physical alterations of the environment, there is a growing recognition that the direct presence of humans themselves may greatly influence how animals behave, including how they perceive risk, move through their habitats, compete for resources, and interact with other species. Despite this, large-scale comparative research has rarely examined human presence as a distinct and dynamic pressure on wildlife, largely due to the fact that detailed data on where and when people move are difficult to obtain. Most existing studies have focused on local settings or broad proxies of human presence, such as pandemic-related lockdowns, and have concentrated largely on mammals. As a result, relatively little is known about how interacting forms of human activity and presence combine to affect wildlife.
To address this gap, Ruth Oliver and colleagues combined data on numbers of mobile devices and vehicles in each U.S. census block as a measure of human presence, along with detailed measures of human landscape modification, with animal tracking data from more than 4,500 birds and mammals representing 37 species. By centering their study on the years 2019 and 2020 and leveraging the unique, temporary decline of human movement in modified landscapes during the COVID-19 pandemic, Oliver et al. were able to disentangle the direct effects of human activity from the broader impacts of landscape change and evaluate how each factor influenced the amount of space animals used. According to the findings, direct human presence influenced the movement patterns or use of the environment of 65% of species examined. Many mammals reduced the amount of territory they used in response to greater human activity, particularly in less-developed habitats where animals may perceive humans as a threat. On the other hand, some species, like gray wolves, expanded their ranges, likely to better avoid people. Adaptable species such as white-tailed deer appeared more comfortable incorporating human-modified environments into their usable habitats. Birds likewise showed highly variable responses, with some species becoming more spatially constrained and others altering their habitat use depending on the surrounding degree of development. In a related Perspective, Lydia Beaudrot discusses the study and its findings in greater detail.
The rapid clinical validation of mRNA technology during the COVID‑19 pandemic has powerfully accelerated its application in oncology, and this comprehensive review provides a state‑of‑the‑art assessment of mRNA cancer vaccines. It systematically covers the molecular design principles of synthetic mRNA, the diverse antigen‑targeting strategies (from conventional tumor‑associated antigens to patient‑specific neoantigens and non‑canonical sources), the major delivery platforms (lipid nanoparticles, lipoplexes, protamine complexes, and cell‑based systems), and the mechanistic pathways by which these vaccines activate both cellular and humoral antitumor immunity. The review then synthesizes preclinical and clinical evidence across solid tumors—melanoma, pancreatic ductal adenocarcinoma, non‑small cell lung cancer, prostate cancer, glioblastoma—and hematologic malignancies, including acute myeloid leukemia, myelodysplastic syndromes, and multiple myeloma. It also critically discusses current challenges, such as the immunosuppressive tumor microenvironment, delivery barriers, and manufacturing complexities, before outlining future directions that involve next‑generation delivery systems, artificial intelligence‑driven vaccine design, and combination strategies with immune checkpoint inhibitors and adoptive T‑cell therapies.
People with severe asthma are often battling multiple health conditions that go undetected, say scientists. A study found that nearly all patients suffer from at least one other major health issue, while most are juggling three or more conditions.
Anti-Asian discrimination and violence increased during COVID, and new research from Murdoch University has revealed one key psychological driver.
(Boston)—Superspreading became a familiar concept to many during the COVID-19 pandemic. Prior studies examining infectious disease epidemics, including those on COVID-19, have found that some individuals are much more likely to transmit infections to other people. Superspreading, when one person with an infection passes it to an unusually large number of other people, is a key feature of tuberculosis (TB) epidemiology. Most individuals with TB, the disease caused by infection with Mycobacterium tuberculosis, cause very few secondary infections, and often cause no secondary infections at all. However, many studies, including groundbreaking studies in the 1950s and 1960s examining TB transmission observed that some individuals with TB are more highly infectious and cause many more secondary infections among their contacts. As a result, the overall impact on future transmission of diagnosing someone with TB and treating them with antibiotics (typically making them non-infectious within 1-2 weeks) can vary widely from person to person.
In a new perspective piece in The Lancet Infectious Diseases, researchers from Boston University Chobanian & Avedisian and the University of Colorado Anschutz School of Medicine examine both historical and contemporary evidence in M. tuberculosis superspreading. They argue it represents not only a critical challenge for global TB control, but also a potential opportunity for innovative prevention strategies. The authors introduce the idea of "superspreading niches", specific parts of community contact networks where highly infectious individuals intersect with highly susceptible contacts, as a key framework for understanding TB superspreading and designing new TB control interventions.
Tracking the genetic diversity of SARS-CoV-2 in wastewater, rather than just viral abundance, dramatically improves the ability to monitor and predict COVID-19 outbreaks, researchers report. Their study suggests that the new approach to wastewater pathogen surveillance could serve as a powerful predictive tool for public health, providing earlier and more accurate insight into emerging waves of infection. Monitoring pathogens in wastewater has become a powerful public health tool since the COVID-19 pandemic, offering a fast, cost-efficient, and potentially less biased way to track infectious diseases across scales. Because wastewater collects biological material from an entire population, a single sample can provide a broad snapshot of community-wide infection dynamics. Yet the standard methods used to estimate disease prevalence, which rely on measuring the amount of viral genetic material recovered from a given volume of wastewater, are vulnerable to limitations. Some measurements cannot be meaningfully compared across different pathogens or settings, while others are easily distorted by environmental factors like rainfall. According to Dustin Hill and colleagues, analyzing pathogen genetic diversity through whole-genome sequencing has the potential to overcome several of the limitations of traditional wastewater surveillance methods. They argue that changes in viral genetic diversity itself may serve as a meaningful indicator of shifts in disease spread within a population.
Here, Hill et al. introduce and validate a method for estimating the prevalence of SARS-CoV-2 by analyzing the virus’s genetic diversity in wastewater. To evaluate this idea, Hill et al. retroactively applied and analyzed genetic diversity within SARS-CoV-2 from 12,290 wastewater samples collected between 2023 and 2025 from across New York state. They found that genetic diversity within a specific region of the viruses’ spike protein – the S1 NTD region – closely tracked real-world COVID-19 infection trends and, in many cases, correlated with disease activity more strongly than traditional wastewater metrics. Moreover, the authors’ statistical analyses revealed that diversity patterns in wastewater consistently preceded increases in COVID-related hospital admissions by one to two weeks, suggesting robust early warning signals of worsening disease spread. “The use of wastewater surveillance as a primary tool for monitoring population health is still a developing area,” write Justin Lessle and Ariel Christensen in a related Perspective. “Nevertheless, [this approach] has the potential to revolutionize infectious disease research and public health practice. Viral sequencing approaches such as that proposed by Hill et al. will be an important component of that success.”
A recent study in Engineering reveals that IgG fucosylation is closely tied to severe COVID-19. Researchers found altered fucosylation—especially a drop in IgG2 fucosylation—in patients, linked to disease severity and body temperature. Key enzymes FUT8 and FUCA1 regulate these changes. The study also shows that Fuzheng Jiedu Decoction may ease inflammation by targeting fucosylation, offering new clues for treating severe COVID-19.
An unprecedented study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2 –the virus responsible for causing COVID-19 disease– based on a treatment that combines two complementary approaches, capable of attacking the virus simultaneously, forcing its instability and hindering its ability to adapt.
Neurological diseases are an increasing public health challenge in China. A recent meta-analysis of 12 disorders shows a rising overall burden, with intracerebral hemorrhage as the leading cause and dementia as the fastest-growing condition. Several disorders rose sharply between 2019 and 2021, coinciding with the onset of the COVID-19 pandemic. These findings indicate shifting disease patterns and highlight the need for improved prevention, early detection, and long-term care strategies nationwide.